AnaptysBio Inc
F:AN6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
AnaptysBio Inc
F:AN6
|
US |
|
S
|
Sumitomo Mitsui Financial Group Inc
F:XMF
|
JP |
|
N
|
Novo Nordisk A/S
DUS:NOVA
|
DK |
|
Inseego Corp
NASDAQ:INSG
|
US |
Wall St Price Targets
AN6 Price Targets Summary
AnaptysBio Inc
According to Wall Street analysts, the average 1-year price target for AN6 is 39.82 EUR with a low forecast of 33.3 EUR and a high forecast of 64.62 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AN6's stock price target?
Price Target
39.82
EUR
According to Wall Street analysts, the average 1-year price target for AN6 is 39.82 EUR with a low forecast of 33.3 EUR and a high forecast of 64.62 EUR.
What is the Revenue forecast for AnaptysBio Inc?
Projected CAGR
12%
Over the last 11 years, the compound annual growth rate for Revenue has been 28%. The projected CAGR for the next 8 years is 12%.
What is the Operating Income forecast for AnaptysBio Inc?
Projected CAGR
39%
Over the last 11 years, the compound annual growth rate for Operating Income has been 23%. The projected CAGR for the next 8 years is 39%.
